+++J. Med. Chem.

[Татка]

Помогите, плиз:
1)Arylpiperazine derivatives as high-affinity 5-HT1A serotonin ligands
Richard A. Glennon, Noreen A. Naiman, Robert A. Lyon, Milt Titeler
J. Med. Chem., 1988, 31 (10), pp 1968–1971
DOI:

DOI:

http://dx.doi.org/10.1021/jm00118a018

2)5-HT1 and 5-HT2: binding characteristics of some quipazine analogs
Richard A. Glennon, R. M. Slusher, Robert A. Lyon, Milt Titeler, J. D. McKenney
J. Med. Chem., 1986, 29 (11), pp 2375–2380
DOI:

DOI:

http://dx.doi.org/10.1021/jm00161a038

3)Higher-End Serotonin Receptors: 5-HT5, 5-HT6, and 5-HT7
Richard A. Glennon†
J. Med. Chem., 2003, 46 (14), pp 2795–2812
DOI:

DOI:

http://dx.doi.org/10.1021/jm030030n

4)Structure−Selectivity Investigations of D2-Like Receptor Ligands by CoMFA and CoMSIA Guiding the Discovery of D3 Selective PET Radioligands
Ismail Salama, Carsten Hocke, Wolfgang Utz,Olaf Prante, Frank Boeckler, Harald Hübner, Torsten Kuwert, and Peter Gmeiner
J. Med. Chem., 2007, 50 (3), pp 489–500
DOI:

DOI:

http://dx.doi.org/10.1021/jm0611152

5)New 5-Hydroxytryptamine1A Receptor Ligands Containing a Norbornene Nucleus: Synthesis and in Vitro Pharmacological Evaluation
Ferdinando Fiorino, Elisa Perissutti, Beatrice Severino, Vincenzo Santagada, Donatella Cirillo, Sara Terracciano, Paola Massarelli, Giancarlo Bruni, Elga Collavoli, Christian Renner, and Giuseppe Caliendo
J. Med. Chem., 2005, 48 (17), pp 5495–5503
DOI:

DOI:

http://dx.doi.org/10.1021/jm050246k

[eFo]

[Татка]

СПАСИБОЧКИ ОГРОМНОЕ))